Last updated on September 2018

A clinical trial to evaluate treatments using Rivaroxaban-Placebo, Rivaroxaban (Xarelto, BAY59-7939) for patients


Brief description of study

The purpose of study is to test whether rivaroxaban added to standard of care treatment, when compared to placebo, has the potential to reduce the incidence of the clinical events related to the clots and complications of the heart and brain (CV death, MI, or stroke) or the legs (acute limb ischemia or major amputation) in patients who had undergone recent procedure(s) to improve the blood flow of their legs.

Clinical Study Identifier: NCT02504216

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )